Announcements Trials
Browse Landscape

Status

Unknown 2Terminated 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Tumor-Agnostic 4Gynecologic 2Genitourinary 2Dermatologic 2Thoracic 1Other solid neoplasm 1Other hematologic neoplasm 1Gastrointestinal 1Breast 1

Conditions

Melanoma 2Skin Neoplasms 1

Interventions

Nivolumab 25pembrolizumab 21Ipilimumab 15Temozolomide 13toripalimab 12Biopsy 10Imiquimod 8Cyclophosphamide 8Dacarbazine 7Blood Specimen Collection 7camrelizumab 6Chemotherapy, Adjuvant 6trametinib 5dabrafenib 5atezolizumab 5aldesleukin 5Gene Expression Profiling 5Cisplatin 5Aminolevulinic Acid 5fludarabine phosphate 4fludarabine 4durvalumab 4binimetinib 4apatinib 4Tomography, Optical Coherence 4Sorafenib 4Photochemotherapy 4Injections 4Bevacizumab 4tislelizumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Data Collection × Dermatologic × Clear all
NCT04485442 2023-11-21

Patient Reported Outcome Measures After Treatment of Skin Cancers on the Face

University Hospital, Basel, Switzerland

Unknown
100 enrolled
Dermatologic

Melanoma, Skin Neoplasms

NCT05641012 2022-12-07

Helioma

Institut Jean-Godinot

Unknown
100 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡